Diazepam binding inhibitory fragment

Discontinued Product

Diazepam binding inhibitory fragment (Cat. No. 1888) has been withdrawn from sale for commercial reasons.
Description: Peripheral benzodiazepine receptor agonist
Alternative Names: DBI (51-70) (human),Eikosaneuropeptide,ENP
Literature (2)

Biological Activity for Diazepam binding inhibitory fragment

Peptide fragment corresponding to residues 51-70 of the human diazepam binding inhibitor protein; peripheral benzodiazepine receptor agonist. Induces intracellular Ca2+ increase and phagocytosis in human neutrophils, mainly through a non-peripheral benzodiazepine receptor-mediated mechanism. Also reduces ammonia-induced swelling in cultured astrocytes.

Technical Data for Diazepam binding inhibitory fragment

M. Wt 2150.39
Formula C91H148N26O32S
Storage Desiccate at -20°C
CAS Number 104360-70-5

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Diazepam binding inhibitory fragment

Certificate of Analysis is currently unavailable on-line.
Please contact Customer Service

References for Diazepam binding inhibitory fragment

References are publications that support the biological activity of the product.

Bender and Norenberg (1998) Effect of benzodiazepines and neurosteroids on ammonia-induced swelling in cultured astrocytes. J.Neurosci.Res. 54 673 PMID: 9843158

Cosentino et al (2000) D.pam-binding inhibitor-derived peptides induce intracellular calcium changes and modulate human neutrophil function. J.Leukoc.Biol. 67 637 PMID: 10811003

Gray et al (1986) Cloning and expression of cDNA for human D.pam binding inhibitor, a natural ligand of an allosteric regulatory site of the γ-aminobutyric acid type A receptor. Proc.Natl.Acad.Sci.U.S.A. 83 7547 PMID: 3020548

View Related Products by Product Action

View all GABAA Receptor Agonists

Keywords: Diazepam binding inhibitory fragment, Diazepam binding inhibitory fragment supplier, Peptide, fragment, corresponding, to, residues, 51-70, of, the, human, diazepam, binding, inhibitors, inhibits, protein;, peripheral, benzodiazepine, receptor, agonist., Induces, intracellular, Ca2+, increase, and, phagocytosis, in, neutrophils, mainly, through, a, non-peripheral, rec, DBI, (51-70), (human), Eikosaneuropeptide, ENP, GABAA, Receptors, Miscellaneous, Compounds, 1888, Tocris Bioscience

Citations for Diazepam binding inhibitory fragment

Citations are publications that use Tocris products.

Currently there are no citations for Diazepam binding inhibitory fragment.

Reviews for Diazepam binding inhibitory fragment

There are currently no reviews for this product. Be the first to review Diazepam binding inhibitory fragment and earn rewards!

Have you used Diazepam binding inhibitory fragment?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

GABA Receptors Scientific Review

GABA Receptors Scientific Review

Written by Ian Martin, Norman Bowery and Susan Dunn, this review provides a history of the GABA receptor, as well as discussing the structure and function of the various subtypes and the clinical potential of receptor modulators; compounds available from Tocris are listed.

Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.